IMV Inc. — Investor Relations & Filings
IMV Inc. is a clinical-stage biopharmaceutical company specializing in immuno-oncology. The company is pioneering a novel class of cancer immunotherapies and vaccines for infectious diseases, such as RSV and COVID-19. Its core unique selling proposition is the proprietary immune-educating platform, known as DPX® technology. This platform is designed to make immunotherapies more effective and broadly applicable across various therapeutic areas, including cancer therapy and infectious diseases. IMV aims to advance its portfolio of DPX-based therapies through clinical development.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| News release - English.pdf | 2023-05-08 | English | |
| News release - English.pdf | 2023-03-31 | English | |
| News release - English.pdf | 2023-03-09 | English | |
| News release - English.pdf | 2023-02-13 | English | |
| News release - English.pdf | 2023-01-09 | English | |
| Material document(s).pdf | 2022-12-22 | English |
Browse filings by year
4 yearsMarket data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
VALIRX PLC
Life science company developing therapeutics for oncology a…
|
VAL | GB | Professional, scientific and te… |
|
Vanta Bioscience Limited
A contract research organization providing preclinical safe…
|
540729 | IN | Professional, scientific and te… |
|
Vaxil Bio Ltd.
Uses a proprietary Signal Peptide platform to develop immun…
|
VXL | CA | Professional, scientific and te… |
|
Vcanbio Cell & Gene Engineering Corp., Ltd
Focuses on stem cell bio-banking, genetic testing, and cell…
|
600645 | CN | Professional, scientific and te… |
|
VECTUS BIOSYSTEMS LIMITED
Develops therapeutics to reverse fibrosis and hypertension …
|
VBS | AU | Professional, scientific and te… |
|
Veradermics, Inc
Clinical-stage biopharmaceutical company developing medical…
|
MANE | US | Professional, scientific and te… |
|
Vera Therapeutics, Inc.
Clinical-stage biotech developing treatments for immunologi…
|
VERA | US | Professional, scientific and te… |
|
Veritas In Silico Inc.
A drug discovery company developing mRNA-targeting therapeu…
|
130A | JP | Professional, scientific and te… |
|
ViGenCell Inc.
Develops immune cell therapies to treat cancer and other in…
|
308080 | KR | Professional, scientific and te… |
|
Viking Therapeutics, Inc.
Clinical-stage biopharma developing therapies for metabolic…
|
VKTX | US | Professional, scientific and te… |
IMV Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/46116/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=46116 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=46116 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=46116 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 46116}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IMV Inc. (id: 46116)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.